Results 31 to 40 of about 25,873,689 (163)
iMeta, Volume 5, Issue 5, October 2026.The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li +29 more
wiley +1 more source
Українська Інтервенційна Нейрорадіологія та Хірургія, 2023 Cavernous hemangiomas (CH) are benign vascular lesions of the central nervous system, which are thin-walled vascular sinusoids without smooth muscle with hemosiderin deposits.
M.S. Gudym, I.M. Bortnik, M.B. Vyval
doaj
Evidence for progressive neurodegeneration in iatrogenic cerebral amyloid angiopathy
Alzheimer's &Dementia, Volume 22, Issue 7, July 2026.Abstract INTRODUCTION Iatrogenic transmission of amyloid beta can cause cerebral amyloid angiopathy (CAA) and Alzheimer's disease (AD), but the relationship between these phenotypes is unclear. METHODS We retrospectively analyzed standardized neuropsychological and neuroimaging data from 11 patients with iatrogenic CAA (iCAA).
Larysa Panteleienko +9 more
wiley +1 more source
Cerebral cavernous hemangioma presented with West syndrome
, 2015 Cerebral cavernous hemangiomas are rarely seen hamartomas of the vascular structure. They are not true neoplasms, but mimic neoplasms clinically and radiologically.
GÜMÜŞ, Hakan +7 more
core +1 more source
The Role of Intraoperative Neurophysiological Monitoring in Intracranial Cavernous Malformation Surgery: A Narrative Review [PDF]
Iranian Journal of Medical SciencesCavernous malformations, also known as cavernous hemangiomas or cavernomas, are abnormal vascular lesions that can occur in various parts of the body, including intracranially.
Mei Shao +6 more
doaj +1 more source
Epilepsia, Volume 67, Issue 7, Page e118-e125, July 2026.Abstract Epilepsy affects more than 50 million individuals globally and has a substantial genetic component that remains to be completely understood. Traditional studies have focused on severe, early onset cases enrolled through clinical or research settings.
Jessica Castrillon Lal +5 more
wiley +1 more source
Journal of Cellular and Molecular Medicine, Volume 30, Issue 13, July 2026.ABSTRACT This study investigates the impact of rapamycin and propranolol on cerebral cavernous malformations (CCMs). Employing an unbiased transcriptomic analysis, we aimed to comprehensively elucidate the molecular mechanisms underlying these drug effects.
Mar García‐Colomer +12 more
wiley +1 more source
Brain and Behavior, Volume 16, Issue 5, May 2026.Chronic inflammatory demyelinating polyneuropathy is an autoimmune disorder causing demyelination, leading to distal weakness, sensory loss, and autonomic dysfunction. Immune activation triggers macrophage‐mediated myelin damage and conduction failure.
Ayesha Khan +11 more
wiley +1 more source
Cavernous hemangioma of the mitral valve – a rare heart tumor. А clinical case [PDF]
, 2018 The article presents a clinical case of a rare benign heart neoplasm – a cavernous mitral valve hemangioma. Infiltrative growth of the tumor led to deformation of the valve with the development of mitral insufficiency and its replacement with a ...
O.A. Pishchurin +4 more
core +1 more source
A GIANT CAVERNOUS HEMANGIOMA OF THE HEART [PDF]
, 2015 Aim. To demonstrate a clinical case of giant cavernous hemangioma of the heart.Material and methods. The operation was done: resection of cavernous hemangioma of the right chambers of the heart and right atrium plastics with xenopericardial patch ...
D. N. Fedorov +6 more
core +1 more source